Pharmacy Medical News about lung cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
Lung Cancer, 10/30/09

Kalikaki A et al. – The data indicate that EGFR mutation status could be predictive for response to cytotoxic front–line chemotherapy in patients with NSCLC. Additional prospective studies are needed in order to validate this observation and to define whether these patients should be preferentially treated with front–line TKIs or chemotherapy.

<< Previous
Incidence and economic burden of suspected adverse events and...

Next >>
Comparison of pharmacokinetics of mycophenolic acid and its...

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09 Relevance Score: 73%

Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09 Relevance Score: 72%

Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09 Relevance Score: 71%

Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09 Relevance Score: 70%

African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09 Relevance Score: 70%